<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01510652</url>
  </required_header>
  <id_info>
    <org_study_id>CR-11-006-HF-ID</org_study_id>
    <nct_id>NCT01510652</nct_id>
  </id_info>
  <brief_title>More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges</brief_title>
  <acronym>MORE-CRT</acronym>
  <official_title>More Options Available With a Quadripolar Left Ventricular (LV) Lead pRovidE In-clinic Solutions to Cardiac Resynchronization Therapy (CRT) Challenges</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is designed with the hypothesis that using a quadripolar left ventricular
      lead results in less interventions when dealing with high pacing thresholds and Phrenic Nerve
      Stimulation (PNS), both at implant and during follow-up, compared to standard bipolar left
      ventricular leads.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lead Performance</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of patients with freedom from event (intra- and post-operative). Intra-operative events were defined as: need to use more than 1 left ventricular lead, need to change lead implant position, use of any device to actively fixate the lead, unsuccessful implant, due to phrenic nerve stimulation, high pacing threshold or lead instability.
Post-operative events were defined as any left ventricular lead related serious adverse device effect and CRT switched off.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Cardiac Resynchronization Therapy Responders</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Percentage of Cardiac Resynchronization Therapy (CRT) responders measured by a decrease of at least 10% of Left Ventricle End-Systolic Volume (LVESV)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implant Duration</measure>
    <time_frame>Total duration of the implant procedure reported at the end of the procedure</time_frame>
    <description>This measure reports the length (in time) of the implantation procedure. The measurement start at skin incision and stop at skin suture (so called skin-to-skin time) The total implant procedure duration time will be compared between the control and the treatment group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1078</enrollment>
  <condition>Postoperative Cardiac Complication</condition>
  <condition>Heart Failure</condition>
  <condition>Left Ventricular Cardiac Dysfunction</condition>
  <condition>Inappropriate Phrenic Nerve Stimulation</condition>
  <condition>Perioperative/Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Quad Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BiP Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BiP Group</intervention_name>
    <description>Implantation of standard Left Ventricular (LV) lead</description>
    <arm_group_label>BiP Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Quad Group</intervention_name>
    <description>Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
    <arm_group_label>Quad Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients are indicated for Cardiac Resynchronization Therapy with Defibrillation
             backup device (CRT-D) implantation, as per current international certified guidelines

          -  Patients age is 18 years or greater

          -  Patients must indicate their understanding of the study and willingness to participate
             by signing the appropriate informed consent form

          -  Patients must be willing and able to comply with all study requirements

        Exclusion Criteria:

          -  Patients with a life expectancy &lt;12 months.

          -  Patients who are or may potentially be pregnant.

          -  Patient has suffered any of the following in the 4 weeks prior to enrolment:

               -  Myocardial Infarction (MI)

               -  Coronary Artery Bypass Graft (CABG)

               -  Unstable Angina Pectoris

          -  Patient has primary valvular disease which has not been corrected
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe Boriani, Pro.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Universitario S. Orsola e Malpighi, Bologna, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital La Citadelle</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Center</name>
      <address>
        <city>Calgary</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QE II Health Sciences</name>
      <address>
        <city>Halifax</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut de Cardiologie du Quebec - Hopital Laval</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HSC Heastern Health</name>
      <address>
        <city>St. Johns</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paijat-Hame Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU La Cavale Blanche</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hopital Albert Michallon</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Cardiovasculaire et Pneumologique Louis Pradel</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital de la Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital du Nord - CH Bourrely St. Antoine</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Hopital G&amp;R Laennec</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hopital de Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Hopital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU St. Etienne</name>
      <address>
        <city>Saint Priest en Jarez</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Tonkin</name>
      <address>
        <city>Villeurbanne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Berlin-Marzahn</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtische Kliniken Bielefeld</name>
      <address>
        <city>Bielefeld</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elisabeth-Krankenhaus</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Greifswald</name>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatskliniken des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludenscheid</name>
      <address>
        <city>Ludenscheid</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtisches Klinikum Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen</name>
      <address>
        <city>Trier</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Escorts Heart Institute and Research Center</name>
      <address>
        <city>New Delhi</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barzilai Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Soroka University Hospital</name>
      <address>
        <city>Beer Sheba</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico S. Orsola &amp; Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S.Anna e S.Sebastiano</name>
      <address>
        <city>Caserta</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Mater Domini</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Maggiore della Carità</name>
      <address>
        <city>Novara</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Casilino</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale SS. Annunziata</name>
      <address>
        <city>Taranto</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Ospedaliera Molinette S. Giovanni Battista</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Maggiore Verona Borgo Trento</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Hospital</name>
      <address>
        <city>Breda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haga Ziekenhuis</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MC Haaglanden</name>
      <address>
        <city>Den Haag</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Slaskie Centrum Chorob Serca</name>
      <address>
        <city>Zabrze</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Basurto</name>
      <address>
        <city>Bilbao</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ramon y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari La Fe</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Basel University Hospital</name>
      <address>
        <city>Basel</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Cantonal Universitaire de Geneva</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione Cardiocentro Ticino</name>
      <address>
        <city>Lugano</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaets Spital Zuerich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Ireland</country>
  </removed_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2011</study_first_submitted>
  <study_first_submitted_qc>January 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2012</study_first_posted>
  <results_first_submitted>August 14, 2015</results_first_submitted>
  <results_first_submitted_qc>September 23, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 23, 2015</results_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac Resynchronization therapy,</keyword>
  <keyword>Heart Failure,</keyword>
  <keyword>Left Ventricular Lead,</keyword>
  <keyword>Quadripolar Left ventricular Lead,</keyword>
  <keyword>Phrenic Nerve Stimulation,</keyword>
  <keyword>Intra and post operative related complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>1078 patients have been enrolled in this study, while 1074 have been randomized to Quad or BiP group.
The randomization procedure happened after the enrollment and before the implant, this explains why not all 1078 patients have been randomized</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Quad Group</title>
          <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet
Quartet Left Ventricular (LV) lead: Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
        </group>
        <group group_id="P2">
          <title>BiP Group</title>
          <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)
Standard Left Ventricular (LV) lead: Implantation of standard Left Ventricular (LV) lead</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="719"/>
                <participants group_id="P2" count="355"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline</title>
              <participants_list>
                <participants group_id="P1" count="718"/>
                <participants group_id="P2" count="348"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="627"/>
                <participants group_id="P2" count="288"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="92"/>
                <participants group_id="P2" count="67"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Quad Group</title>
          <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet
Quartet Left Ventricular (LV) lead: Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
        </group>
        <group group_id="B2">
          <title>BiP Group</title>
          <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)
Standard Left Ventricular (LV) lead: Implantation of standard Left Ventricular (LV) lead</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="718"/>
            <count group_id="B2" value="348"/>
            <count group_id="B3" value="1066"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.6" spread="10.2"/>
                    <measurement group_id="B2" value="68.4" spread="9.7"/>
                    <measurement group_id="B3" value="67.9" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="173"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="247"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="545"/>
                    <measurement group_id="B2" value="274"/>
                    <measurement group_id="B3" value="819"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular Ejection Fraction (LVEF)</title>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.1" spread="7.6"/>
                    <measurement group_id="B2" value="27.5" spread="8.1"/>
                    <measurement group_id="B3" value="27.2" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular End-Diastolic Volume (LVEDV)</title>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="200.4" spread="74.9"/>
                    <measurement group_id="B2" value="204.5" spread="72.0"/>
                    <measurement group_id="B3" value="203.2" spread="80.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular End-Systolic Volume (LVESV)</title>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="151.2" spread="64.0"/>
                    <measurement group_id="B2" value="149.0" spread="58.3"/>
                    <measurement group_id="B3" value="150.5" spread="62.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>QRS duration</title>
          <units>ms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="158" spread="29"/>
                    <measurement group_id="B2" value="157" spread="27"/>
                    <measurement group_id="B3" value="157.5" spread="28.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiomyopathy</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Ischemic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="353"/>
                    <measurement group_id="B2" value="196"/>
                    <measurement group_id="B3" value="549"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non Ischemic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="365"/>
                    <measurement group_id="B2" value="152"/>
                    <measurement group_id="B3" value="517"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Atrial Arrhythmia History</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Atrial Fibrillation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Atrial Flutter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="583"/>
                    <measurement group_id="B2" value="283"/>
                    <measurement group_id="B3" value="866"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lead Performance</title>
        <description>Percentage of patients with freedom from event (intra- and post-operative). Intra-operative events were defined as: need to use more than 1 left ventricular lead, need to change lead implant position, use of any device to actively fixate the lead, unsuccessful implant, due to phrenic nerve stimulation, high pacing threshold or lead instability.
Post-operative events were defined as any left ventricular lead related serious adverse device effect and CRT switched off.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Quad Group</title>
            <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet
Quartet Left Ventricular (LV) lead: Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
          </group>
          <group group_id="O2">
            <title>BiP Group</title>
            <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)
Standard Left Ventricular (LV) lead: Implantation of standard Left Ventricular (LV) lead</description>
          </group>
        </group_list>
        <measure>
          <title>Lead Performance</title>
          <description>Percentage of patients with freedom from event (intra- and post-operative). Intra-operative events were defined as: need to use more than 1 left ventricular lead, need to change lead implant position, use of any device to actively fixate the lead, unsuccessful implant, due to phrenic nerve stimulation, high pacing threshold or lead instability.
Post-operative events were defined as any left ventricular lead related serious adverse device effect and CRT switched off.</description>
          <units>% of patients with freedom from event</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="719"/>
                <count group_id="O2" value="355"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                    <measurement group_id="O2" value="74.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Cardiac Resynchronization Therapy Responders</title>
        <description>Percentage of Cardiac Resynchronization Therapy (CRT) responders measured by a decrease of at least 10% of Left Ventricle End-Systolic Volume (LVESV)</description>
        <time_frame>Baseline and 6 months</time_frame>
        <population>The number of participants analyzed is the number of patients with echo data received for both baseline and 6 months follow up visits (and so comparable)</population>
        <group_list>
          <group group_id="O1">
            <title>Quad Group</title>
            <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet
Quartet Left Ventricular (LV) lead: Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
          </group>
          <group group_id="O2">
            <title>BiP Group</title>
            <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)
Standard Left Ventricular (LV) lead: Implantation of standard Left Ventricular (LV) lead</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Cardiac Resynchronization Therapy Responders</title>
          <description>Percentage of Cardiac Resynchronization Therapy (CRT) responders measured by a decrease of at least 10% of Left Ventricle End-Systolic Volume (LVESV)</description>
          <population>The number of participants analyzed is the number of patients with echo data received for both baseline and 6 months follow up visits (and so comparable)</population>
          <units>% of patients that are CRT responders</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="476"/>
                <count group_id="O2" value="218"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.0"/>
                    <measurement group_id="O2" value="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Implant Duration</title>
        <description>This measure reports the length (in time) of the implantation procedure. The measurement start at skin incision and stop at skin suture (so called skin-to-skin time) The total implant procedure duration time will be compared between the control and the treatment group.</description>
        <time_frame>Total duration of the implant procedure reported at the end of the procedure</time_frame>
        <population>The number of participants analyzed is the number of patients with implant data duration time available.</population>
        <group_list>
          <group group_id="O1">
            <title>Quad Group</title>
            <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet
Quartet Left Ventricular (LV) lead: Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
          </group>
          <group group_id="O2">
            <title>BiP Group</title>
            <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)
Standard Left Ventricular (LV) lead: Implantation of standard Left Ventricular (LV) lead</description>
          </group>
        </group_list>
        <measure>
          <title>Implant Duration</title>
          <description>This measure reports the length (in time) of the implantation procedure. The measurement start at skin incision and stop at skin suture (so called skin-to-skin time) The total implant procedure duration time will be compared between the control and the treatment group.</description>
          <population>The number of participants analyzed is the number of patients with implant data duration time available.</population>
          <units>min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="710"/>
                <count group_id="O2" value="342"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.4" spread="54.5"/>
                    <measurement group_id="O2" value="101.1" spread="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 Months: From the enrollment to 6 Months Follow Up</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Quad Group</title>
          <description>Patients in the Quad group will be implanted with St. Jude Medical (SJM) quadripolar Left Ventricular (LV) lead Quartet
Quartet Left Ventricular (LV) lead: Implantation of quadripolar Left ventricular (LV) lead Quartet</description>
        </group>
        <group group_id="E2">
          <title>BiP Group</title>
          <description>Patients in the BiP Group will be implanted with a standard (regulatory approved and commercially available) bipolar left ventricular lead from other companies (non St. Jude Medical leads)
Standard Left Ventricular (LV) lead: Implantation of standard Left Ventricular (LV) lead</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="332" subjects_at_risk="719"/>
                <counts group_id="E2" subjects_affected="211" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="55" subjects_affected="53" subjects_at_risk="719"/>
                <counts group_id="E2" events="35" subjects_affected="35" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" events="55" subjects_affected="41" subjects_at_risk="719"/>
                <counts group_id="E2" events="30" subjects_affected="24" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Other - Cardiac</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="719"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other - Non Cardiac</sub_title>
                <counts group_id="E1" events="83" subjects_affected="81" subjects_at_risk="719"/>
                <counts group_id="E2" events="51" subjects_affected="48" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Death for Unknown Causes</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="719"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="719"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="719"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Cardiac Perforation (RV Lead)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Coronary Sinus Dissection (LV Lead related)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Coronary Sinus Dissection (Other Device related)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="719"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Phrenic Nerve Stimulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pulmonary Edema</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="719"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pocket Erosion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Lead Dislodgement (LV Lead)</sub_title>
                <counts group_id="E1" events="37" subjects_affected="37" subjects_at_risk="719"/>
                <counts group_id="E2" events="22" subjects_affected="20" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Fracture (LV Lead)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Dislodgement (RA Lead)</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="719"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Dislodgement (RV Lead)</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="719"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Fracture (RV Lead)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Malfunction (RA Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Unstable Position (LV Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Loss of Capture (RV Lead)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="186" subjects_at_risk="719"/>
                <counts group_id="E2" subjects_affected="76" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="29" subjects_affected="28" subjects_at_risk="719"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Heart Failure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="719"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Other - Cardiac</sub_title>
                <counts group_id="E1" events="24" subjects_affected="19" subjects_at_risk="719"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other - Non Cardiac</sub_title>
                <counts group_id="E1" events="43" subjects_affected="42" subjects_at_risk="719"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="719"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Cardiac Perforation (Other Device Related)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Coronary Sinus Dissection (LV Lead Related)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="719"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Phrenic Nerve stimulation</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="719"/>
                <counts group_id="E2" events="14" subjects_affected="11" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Lead Damaged during Implant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Dislodgement (LV Lead)</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="719"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Coronary Sinus Dissection (Other Device Related)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="719"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>High Voltage Lead Impedance (RV Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Lead Dislodgement (RA Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Loss Of Capture (LV Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Oversensing (RV Lead)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pacing Impedance Out Of Range (LV Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
              <event>
                <sub_title>Pacing Impedance Out Of Range (RV Lead)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="719"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="355"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Patients were followed for only 6 months, studies with longer follow-up would add to the body of evidence.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Prof. Giuseppe Boriani</name_or_title>
      <organization>Institute of Cardiology, Univ. of Bologna, Bologna, Italy</organization>
      <email>giuseppe.boriani@unibo.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

